Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early TXA in Hip Fractures
NCT04488367Phase 1Unknown
- Sponsor
- Community Memorial Health System
- Start
- Jul 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tranexamic acid in hemorrhage (2 arms), sponsored by Community Memorial Health System. Primary endpoints: Change in calculated and recorded hemoglobin at 4 weeks and Total postoperative units of red blood cell transfusion at 4 weeks. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04488367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488367.